Abstract:Objective To evaluate the value of nuchal translucency(NT) as a screening test for fetal abnormalities in the first trimester ultrasound examination.Methods A search in Cochrane Library,PubMed,OVID,Springer,China National Knowledge Infrastructure(CNKI) and Chinese Bio-medicine Database(CBM)was performed to identify relevant English and Chinese articles between Jan 1990 and August 2008.Criteria for inclusion were established based on validity criteria for diagnostic research.Subsequently,the characteristics of the included articles were extracted.Statistical analysis was performed with Meta-DiSc 1.4.Heterogeneity of the included articles was tested to select proper effect model to calculate pooled weighted sensitivity and specificity.Summary receiver operating characteristic curve(SROC) was made and the area under the curve(AUC) was calculated.Finally,sensitivity analysis was performed.Results Twelve articles were included,with a total of 112 099 fetuses.Nine articles meeting inclusion criteria were analyzed for the value of screening for cardiac abnormalities by nuchal translucency thickness above the 95th percentile for gestational age.The pooled sensitivity and specificity was 29.8%,96.9%,respectively,AUC=0.804 7.Seven articles meeting inclusion criteria were analyzed for the value of screening for cardiac abnormalities by nuchal translucency thickness above the 99th percentile for gestational age.The pooled sensitivity and specificity was 18.9%,99.3%,respectively,AUC=0.971 2.Five articles meeting inclusion criteria were analyzed for the value of screening for fetal abnormalities by nuchal translucency thickness above the 95th percentile for gestational age.The pooled sensitivity and specificity was 25.0%,98.3% respectively,AUC=0.183 0.The sensitivity of screening for cardiac abnormalities by nuchal translucency thickness above the 95th percentile for gestational age was significantly higher than the nuchal translucency thickness above the 99th percentile for gestational age(χ2=6.58,P0.05),no difference was found in the specificity.The random-effect model was used in the analysis of screening for cardiac abnormalities by nuchal translucency thickness above the 95th or 99th percentile for gestational age because of the heterogeneity.The fixed-effect model was used in the analysis of screening for fetal abnormalities by nuchal translucency thickness above the 95th percentile for gestational age because of the homogenicity.Conclusions The results suggest that screening for fetal abnormalities by NT thickness above the 95th percentile for gestational age has a low accuracy and is unsuitable for prenatal screen.At present it is incompletely clear on the sensitivity and specificity of screening for different kinds of fetal abnormalities by NT thickness.Screening for cardiac abnormalities by first trimester NT thickness has a high accuracy and specificity and can be reliably used in prenatal screen.We need the further systemic reviews to evaluate the value of NT as a screening test for different kinds of fetal abnormalities.Further multi-centre and prospective studies are badly needed to be performed to optimize the standard of nuchal translucency thickness,evaluate the value of NT as a screening test for fetal abnormalities(especially cardiac abnormalities) in the first trimester ultrasound examination by a cost-effectiveness analysis,and develop an operation guideline on first trimester nuchal translucency thickness measurement for the prenatal screening of cardiac abnormalities in China.

Combination prenatal ultrasound screening in early and middle stage of pregnancy for detecting fetal abnormalities

The essentiality of prenatal ultrasound screening of fetal malformations in the first trimester

[Study on Several Ultrasound Markers Combined Maternal Serum Biochemical Markers to Screen Fetal Chromosomal Aneuploidy at 11 to 13(+)6 Weeks of Gestation].

Clinical value of standardized prenatal ultrasonography in diagnosis of twin abnormalities during early trimester

First-trimester screening for fetal structural and chromosomal anomalies by detailed early anomaly scan

Clinical Value of Prenatal Ultrasonography in Diagnosis of Fetal Abnormalities in Fertilization-Embryo Transfer During Early Trimester

Clinical Value of Structural Screening by Ultrasound in Diagnosis of Fetal Central Nervous System Malformations at 11 ~ 13+6 Weeks of Gestation

Study on the Application of Ultrasonography in the Diagnosis of Fetal Cardiac Structural Abnormalities and the Relationship Between Fetal Cardiac Structural Abnormalities with Chromosome Abnormalities in Early Pregnancy.

The Correlation for Prenatal Ultrasound Screening of Fetal Malformations and Fetal Chromosomal Abnormality

Clinical Value and Effectiveness of Sonography Screening for Fetal Chromosomal Abnormalities in the Middle and Late Pregnancy

Comparation of Ultrasound Screening for 11-13+6 Versus 14-17+6 Week Fetus

The Value of Combined Detailed First-Trimester Ultrasound–biochemical Analysis for Screening Fetal Aneuploidy in the Era of Non-Invasive Prenatal Testing

The value of detailed first-trimester ultrasound in the era of noninvasive prenatal testing

Meta-analysis of the Value of Nuchal Translucency As a Screening Test for Fetal Abnormalities in the First Trimester Ultrasound Examination

Diagnosed value of ultrasonography in fetal central nervous system dysmorphosis during 11-13+6 weeks'gestation

Meta-analysis of Screening for Chromosomal Abnormalities Using Elevated Nuchal Translucency in First Trimester

The application value of fetal nuchaltranslucency(NT)obtatained in first trimesterindetecting fetal deformities

Clinical value of prenatal ultrasonography in diagnosis of multiple fetal megacystis during early trimester

First-Trimester Combined Screening is Effective for the Detection of Unbalanced Chromosomal Translocations at 11 to 12 Weeks of Gestation

A Preliminary Clinical Study of Three-Dimensional Ultrasonography in Prenatal Diagnosis.

Middle Pregnancy Ultrasound Screening for Fetal Chromosomal Diseases